Tsuneyoshi Naoko, Kohara Jun, Bahrun Uleng, Saitoh Shin-ichiroh, Akashi Sachiko, Gauchat Jean-François, Kimoto Masao, Fukudome Kenji
Department of Immunology, Saga Medical School, 5-1-1 Nabeshima, Saga 849-8501, Japan.
Cell Immunol. 2006 Nov;244(1):57-64. doi: 10.1016/j.cellimm.2007.02.010. Epub 2007 Apr 8.
A mutant lipopolysaccharide (LPS) lacking a myristate chain in lipid A was shown to be non-pathogenic both in humans and mice. The mutant penta-acylated LPS from the lpxM-strain did not induce TNF-alpha production in murine peritoneal macrophages, or activation of NF-kappaB in transfected cells expressing murine TLR4/MD-2. We prepared a recombinant murine MD-2 in Escherichia coli (E. coli), and examined the binding function. Unexpectedly, specific binding was detected to both wild type and mutant LPS. However, the mutant LPS did not induce conformation changes or oligomerization of TLR4, which have been shown to be required for signal transduction. Mutant LPS appears to fail to induce appropriate conformational changes, resulting in oligomerization of the murine complex for triggering cell responses.
一种脂质A中缺乏肉豆蔻酸链的突变型脂多糖(LPS)在人和小鼠中均显示无致病性。来自lpxM菌株的突变型五酰化LPS不会在小鼠腹膜巨噬细胞中诱导肿瘤坏死因子-α(TNF-α)的产生,也不会在表达小鼠Toll样受体4(TLR4)/髓样分化蛋白2(MD-2)的转染细胞中激活核因子-κB(NF-κB)。我们在大肠杆菌中制备了重组小鼠MD-2,并检测了其结合功能。出乎意料的是,野生型和突变型LPS均能检测到特异性结合。然而,突变型LPS不会诱导TLR4的构象变化或寡聚化,而这已被证明是信号转导所必需的。突变型LPS似乎无法诱导适当的构象变化,从而导致触发细胞反应的小鼠复合物寡聚化。